Health
Astra, Pfizer Covid Vaccines to Be Combined in Oxford Trial – BloombergQuint
Astra, Pfizer Covid Vaccines to Be Combined in Oxford Trial
(Bloomberg) — The University of Oxford is set to begin a trial combining Covid-19 vaccines from AstraZeneca Plc and Pfizer Inc. that could enable greater flexibility in the use of scarce supplies globally.
The university will begin recruiting 820 participants over 50 years of age across eight U.K. sites this week, according to a statement Thursday. The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.
The trial will allow researchers…
-
Business19 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General17 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News19 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
-
General14 hours ago‘Brilliant time capsule’ of historical street images returns to Bendigo